Wednesday 3 October 2007

Introductions and overview – Educational objectives of the programme - David Gerrett (UK)
Download PDF

Setting the scene – the questions that need to be answered when selecting a biological - Wim Jiskoot (The Netherlands)
Download PDF

Case study: what can go wrong? - Huub Schellekens (The Netherlands)
Download PDF

Molecular biotechnology - Harald Sitte (Austria)
Download PDF

Structure and analysis of recombinant proteins - Wim Jiskoot (The Netherlands)
Download PDF

Production and downstream processing/purification - Wim Jiskoot (The Netherlands)
Download PDF

Formulation - Bruno Gander (Switzerland)
Download PDF

Route of administration, including biopharmaceutical considerations - Harald Sitte (Austria)
Download PDF

PK/PD of peptide and protein drugs - Harald Sitte (Austria)
Download PDF

Drug design - Harald Sitte (Austria)
Download PDF

What have we learned? How will we teach it? What will we do tomorrow? - David Gerrett (UK)
Download PDF

Thursday 4 October 2007

Welcome and recap on the day’s agenda - David Gerrett (UK)
Download PDF

Safety of biological pharmaceuticals -  Huub Schellekens (The Netherlands)
Download PDF

Basic methodologies in biotechnology - Harald Sitte (Austria)
Download PDF

Clinical trials - David Gerrett (UK)
Download PDF

Biosimilars - Huub Schellekens (The Netherlands)
Download PDF

Biopharmaceuticals and shifting paradigms - Daan Crommelin (The Netherlands)
Download PDF

Friday 5 October 2007

Pharmacoeconomics - David Gerrett (UK)
Download PDF